275 related articles for article (PubMed ID: 8375272)
1. Improvement in blunted glucagon response to insulin-induced hypoglycemia by strict glycemic control in diabetics.
Katsura M; Kawamori R; Yamasaki Y; Iwama N; Kubota M; Goriya Y; Kajimoto Y; Shichiri M; Kamada T
Diabetes Res Clin Pract; 1993 May; 20(2):93-100. PubMed ID: 8375272
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of the blunted glucagon response to insulin-induced hypoglycemia in diabetics].
Katsura M
Nihon Naibunpi Gakkai Zasshi; 1986 Nov; 62(11):1276-88. PubMed ID: 3542595
[TBL] [Abstract][Full Text] [Related]
3. Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM.
Levy CJ; Kinsley BT; Bajaj M; Simonson DC
Diabetes Care; 1998 Aug; 21(8):1330-8. PubMed ID: 9702443
[TBL] [Abstract][Full Text] [Related]
4. Loss of potentiating effect of hypoglycemia on the glucagon response to hyperaminoacidemia in IDDM.
Caprio S; Tamborlane WV; Zych K; Gerow K; Sherwin RS
Diabetes; 1993 Apr; 42(4):550-5. PubMed ID: 8454105
[TBL] [Abstract][Full Text] [Related]
5. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
[TBL] [Abstract][Full Text] [Related]
6. Urinary C-peptide as an index of unstable glycemic control in insulin-dependent diabetes mellitus (IDDM).
Cha T; Tahara Y; Ikegami H; Fukuda M; Yoneda H; Yamato E; Yamamoto Y; Noma Y; Shima K; Ogihara T
Diabetes Res Clin Pract; 1991 Sep; 13(3):181-7. PubMed ID: 1959481
[TBL] [Abstract][Full Text] [Related]
7. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of exaggerated glucagon response to arginine in diabetes mellitus.
Kawamori R; Shichiri M; Kikuchi M; Yamasaki Y; Abe H
Diabetes Res Clin Pract; 1985 Oct; 1(3):131-7. PubMed ID: 3915260
[TBL] [Abstract][Full Text] [Related]
9. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
Popp DA; Shah SD; Cryer PE
J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
[TBL] [Abstract][Full Text] [Related]
10. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance.
Del Prato S; Matsuda M; Simonson DC; Groop LC; Sheehan P; Leonetti F; Bonadonna RC; DeFronzo RA
Diabetologia; 1997 Jun; 40(6):687-97. PubMed ID: 9222649
[TBL] [Abstract][Full Text] [Related]
11. Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans.
Davis MR; Shamoon H
Metabolism; 1992 Feb; 41(2):216-23. PubMed ID: 1736045
[TBL] [Abstract][Full Text] [Related]
12. Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes.
Sjöberg S; Ahrén B; Bolinder J
J Intern Med; 2002 Oct; 252(4):342-51. PubMed ID: 12366607
[TBL] [Abstract][Full Text] [Related]
13. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE
Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of circulating insulin on glucagon secretion during hypoglycemia in type I diabetic patients.
Liu DT; Adamson UC; Lins PE; Kollind ME; Moberg EA; Andréasson K
Diabetes Care; 1992 Jan; 15(1):59-65. PubMed ID: 1346593
[TBL] [Abstract][Full Text] [Related]
15. Improved counter-regulatory hormonal and symptomatic responses to hypoglycemia in patients with insulin-dependent diabetes mellitus after 3 months of less strict glycemic control.
Liu D; McManus RM; Ryan EA
Clin Invest Med; 1996 Apr; 19(2):71-82. PubMed ID: 8697673
[TBL] [Abstract][Full Text] [Related]
16. Plasma catecholamine responses to hypoglycemia in children and adolescents with IDDM.
Hoffman RP; Singer-Granick C; Drash AL; Becker DJ
Diabetes Care; 1991 Feb; 14(2):81-8. PubMed ID: 2060427
[TBL] [Abstract][Full Text] [Related]
17. Glucagon responses to hypoglycemia in children and adolescents with IDDM.
Singer-Granick C; Hoffman RP; Kerensky K; Drash AL; Becker DJ
Diabetes Care; 1988 Sep; 11(8):643-9. PubMed ID: 3065002
[TBL] [Abstract][Full Text] [Related]
18. Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits.
Powell AM; Sherwin RS; Shulman GI
J Clin Invest; 1993 Dec; 92(6):2667-74. PubMed ID: 8254023
[TBL] [Abstract][Full Text] [Related]
19. The effect of glycemic variability on counterregulatory hormone responses to hypoglycemia in young children and adolescents with type 1 diabetes.
Alghothani N; Dungan KM
Diabetes Technol Ther; 2011 Nov; 13(11):1085-9. PubMed ID: 21770764
[TBL] [Abstract][Full Text] [Related]
20. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM.
Fanelli CG; Epifano L; Rambotti AM; Pampanelli S; Di Vincenzo A; Modarelli F; Lepore M; Annibale B; Ciofetta M; Bottini P
Diabetes; 1993 Nov; 42(11):1683-9. PubMed ID: 8405713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
